CONSORT 2010 statement: Updated guidelines for reporting parallel group randomised trials (Chinese version)

K.F. Schulz, D.G. Altman, D. Moher, V. Barbour, J.A. Berlin, I. Boutron, P.J. Devereaux, K. Dickersin, D. Elbourne, S. Ellenberg, V. Gebski, S. Goodman, P.C. Gøtzsche, T. Groves, S. Grunberg, B. Haynes, S. Hopewell, A. James, P. Juhn, P. MiddletonD. Minckler, V.M. Montori, C. Mulrow, S. Pocock, D. Rennie, D.L. Schriger, I. Simera, E. Wager, M. Clarke, G. Guyatt

    Research output: Contribution to journalArticlepeer-review

    184 Citations (Scopus)

    Abstract

    The CONSORT statement is used worldwide to improve the reporting of randomised controlled trials. Kenneth Schulz and colleagues describe the latest version, CONSORT 2010, which updates the reporting guideline based on new methodological evidence and accumulating experience. To encourage dissemination of the CONSORT 2010 Statement, this article is freely accessible on bmj.com and will also be published in the Lancet, Obstetrics and Gynecology, PLoS Medicine, Annals of Internal Medicine, Open Medicine, Journal of Clinical Epidemiology, BMC Medicine, and Trials.
    Original languageEnglish
    Pages (from-to)604-612
    Number of pages9
    JournalJournal of Chinese Integrative Medicine
    Volume8
    Issue number7
    DOIs
    Publication statusPublished - 2010

    Bibliographical note

    Cited By :101

    Fingerprint

    Dive into the research topics of 'CONSORT 2010 statement: Updated guidelines for reporting parallel group randomised trials (Chinese version)'. Together they form a unique fingerprint.

    Cite this